Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription 17.08.2026 4 AIDS 1 AIDS Res Hum Retroviruses 1 Arch Dis Child 5 Clin Infect Dis 1 Drugs 2 HIV Med 1 J Infect Dis 2 J Virol 2 Lancet 1 Lancet Infect Dis 1 MMWR Morb Mortal Wkly Rep 1 Nat Med 1 Nature 1 PLoS Comput Biol 6 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. O'CONNOR L, Monroe A, Ji Y, Baskaran A, et al
   Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.
   AIDS. 2026 Aug 13. doi: 10.1097/QAD.0000000000004606.
   PubMed         Abstract available
   
   
2. KOSS CA, Kamya MR, Nyabuti M, Okochi H, et al
   Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.
   AIDS. 2026 Aug 13. doi: 10.1097/QAD.0000000000004605.
   PubMed         Abstract available
   
   
3. TIWARI R, Collett BR, Oucho I, Otieno C, et al
   Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).
   AIDS. 2026 Aug 13. doi: 10.1097/QAD.0000000000004608.
   PubMed         Abstract available
   
   
4. LEFEBVRE S, Goujard C, Meyer L, Durier C, et al
   Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.
   AIDS. 2026 Aug 11. doi: 10.1097/QAD.0000000000004602.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

5. LIU H, He Y, Yang T, Cai L, et al
   Efficacy and Safety of Albuvirtide Plus Dolutegravir or Dolutegravir/Lamivudine in Hospitalized People with Advanced AIDS: A Retrospective Real-World Study.
   AIDS Res Hum Retroviruses. 2026 Aug 10:8892229261394656.
   PubMed         Abstract available
   
   

   
   Arch Dis Child

6. DADKHAH TIRANI D, Zhang C, Bose R, Kumbakumba E, et al
   Unplanned discharges and their impact on postdischarge mortality in Ugandan children: a multisite cohort study.
   Arch Dis Child. 2026 Aug 13:archdischild-2025-330051.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

7. ETIENNEY I, Singh D, Ressiot E, Didelot JM, et al
   Evolution of Untreated Anal High-grade Squamous Intraepithelial Lesions in High-risk Men: A Prospective 5-year Clinical Follow-up in the ANRS-EP57-APACHES study.
   Clin Infect Dis. 2026 Aug 14:ciag477. doi: 10.1093.
   PubMed         Abstract available
   
   
8. 
   Correction to: Low Trauma Fractures in People With HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study, 2009-2022.
   Clin Infect Dis. 2026 Aug 13:ciag472. doi: 10.1093.
   PubMed        
   
   
9. 
   Correction to: Switch to Bictegravir/Tenofovir Alafenamide/Emtrictabine or Dolutegravir + Tenofovir Disoproxil Fumarate/Emtrictabine in Virologically Suppressed People With HIV: Outcomes in Real-world Setting With and Without Tenofovir Resistance.
   Clin Infect Dis. 2026 Aug 13:ciag488. doi: 10.1093.
   PubMed        
   
   
10. MCMANUS KA, Killelea A, Horn T
    Clinical Excellence Amidst Fiscal Erosion: ADAP and the Ending the HIV Epidemic Initiative.
    Clin Infect Dis. 2026 Aug 12:ciag413. doi: 10.1093.
    PubMed        
    
    
11. MCCRARY LM, Curtis MR, Kelly JC, Elrod-Gallegos J, et al
    Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy.
    Clin Infect Dis. 2026 Aug 11:ciag422. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Drugs

12. BLAIR HA
    Lenacapavir: A Review in HIV Pre-Exposure Prophylaxis.
    Drugs. 2026 Aug 13. doi: 10.1007/s40265-026-02368.
    PubMed         Abstract available
    
    

    
    HIV Med

13. MAFUTA C, Grabar S, Lievre L, Goujard C, et al
    Psychosocial vulnerabilities and loss to follow-up in people living with HIV in France.
    HIV Med. 2026 Aug 13. doi: 10.1111/hiv.70293.
    PubMed         Abstract available
    
    
14. LAYMOUNA M, Engler K, Lessard D, Belin M, et al
    Material deprivation and its correlates in treatment-naive migrants with HIV with rapid access to B/F/TAF at no cost: A sub-study of the ASAP cohort.
    HIV Med. 2026 Aug 13. doi: 10.1111/hiv.70299.
    PubMed         Abstract available
    
    

    
    J Infect Dis

15. SHAH A, Sacdalan C, Gorelick R, Macmath D, et al
    Preferential Reservoir Seeding in HPV16-Specific CD4-T-Cells During HIV-1 Acute and Chronic Infection.
    J Infect Dis. 2026 Aug 14:jiag424. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

16. LAMCAJ S, Cole E, Hiner C, Santos Bravo M, et al
    Enhancing HIV-1-specific CAR-T cell functional activity by treatment with a novel cytokine-based scaffold with IL-15 superagonist and TGF-beta-neutralizing activity.
    J Virol. 2026 Aug 14:e0005126. doi: 10.1128/jvi.00051.
    PubMed         Abstract available
    
    
17. KILROY JM, Deokar AA, Patalano S, Fuxman Bass JI, et al
    Intragenic transcription from defective HIV proviruses triggers interferon responses in myeloid cells.
    J Virol. 2026 Aug 10:e0055226. doi: 10.1128/jvi.00552.
    PubMed         Abstract available
    
    

    
    Lancet

18. COLSON AE, Kumar PN, Ruane PJ, Chetchotisakd P, et al
    Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.
    Lancet. 2026 Aug 12:S0140-6736(26)01442-X. doi: 10.1016/S0140-6736(26)01442.
    PubMed         Abstract available
    
    
19. DEL MAR ARCOS M, Arribas JR
    Once-weekly oral antiretroviral therapy for HIV.
    Lancet. 2026 Aug 12:S0140-6736(26)01557-6. doi: 10.1016/S0140-6736(26)01557.
    PubMed        
    
    

    
    Lancet Infect Dis

20. PHILLIPS PPJ, Schumacher SG, Cassino C, Charalambous S, et al
    Guiding principles for pragmatic randomised trials of tuberculosis treatments.
    Lancet Infect Dis. 2026 Aug 14:S1473-3099(26)00359.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

21. LOCHEN A, Pang D, Howard S, Padilla R, et al
    Notes from the Field: Potential Infant HIV Exposure from Donated Breast Milk Received Through Social Media - Santa Clara County, California, May 2025-January 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:403-404.
    PubMed        
    
    

    
    Nat Med

22. TEUFEL F, Chandiwana N, Shivashankar R, Manne-Goehler J, et al
    Global access to different classes of diabetes medicines: a framework for targeted policy actions.
    Nat Med. 2026 Aug 10. doi: 10.1038/s41591-026-04579.
    PubMed        
    
    

    
    Nature

23. GNANAKARAN S, Derdeyn CA
    HIV vaccines guide rare immune cells to make broadly neutralizing antibodies.
    Nature. 2026 Aug 11. doi: 10.1038/d41586-026-02374.
    PubMed        
    
    

    
    PLoS Comput Biol

24. WANG E, Chakraborty AK
    Design of an immunogen containing multidimensionally conserved and immunogenic parts of the HIV proteome.
    PLoS Comput Biol. 2026;22:e1014632.
    PubMed         Abstract available
    
    

    
    PLoS One

25. FARAJI N, Rouhi L, Bolhassani A, Hasannejad-Asl B, et al
    Prediction of potential biomarkers and therapeutic targets in HIV viremic patients using immune-related circRNA-miRNA-mRNA regulatory networks.
    PLoS One. 2026;21:e0355600.
    PubMed         Abstract available
    
    
26. GUMUDAVELLY D, Kiggundu JB, Ayebare F, Kiwala C, et al
    "Just trying to make it work:" A qualitative exploration of healthcare provider implementation considerations for integrating mental health and HIV care in central Uganda.
    PLoS One. 2026;21:e0353859.
    PubMed         Abstract available
    
    
27. ZHANG H, Chen W, Yuan S, Ding S, et al
    Unraveling the molecular Nexus of Alzheimer's Disease and HIV encephalitis: The role of cellular senescence and transcriptional regulation.
    PLoS One. 2026;21:e0355548.
    PubMed         Abstract available
    
    
28. MBONSHI B, Kabemba EM, Bowa C
    Prevalence and determinants of soil transmitted helminth infections among children on Highly Active Antiretroviral Therapy (HAART) in Mulobezi and Sesheke Districts, Zambia: A cross - sectional study.
    PLoS One. 2026;21:e0356060.
    PubMed         Abstract available
    
    
29. KALABA D, Chanda C, Mputu M, Benson HM, et al
    Determinants of favorable treatment outcomes in multidrug-resistant tuberculosis in Zambia: A retrospective cross sectional study, 2018-2022.
    PLoS One. 2026;21:e0355721.
    PubMed         Abstract available
    
    
30. IRIEMENAM NC, Osawe S, Akanbi OA, Akinmulero O, et al
    High prevalence of SARS-CoV-2 antibodies among frontline healthcare workers during the COVID-19 pandemic in three states of Nigeria from August to December 2022.
    PLoS One. 2026;21:e0354606.
    PubMed         Abstract available
    
    

    
    Vaccine

31. RAFIZADEH A, Wijekoon D, Aung ET, Aguirre I, et al
    Influenza vaccination uptake among people living with HIV in Melbourne, 2015-2025: a repeated cross-sectional study.
    Vaccine. 2026;90:129038.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum